Recorded Presentation from the 2017 NCCN Case Manager and Medical Director Program: Transitioning from Patient with Cancer to Cancer Survivor

Join Crystal S. Denlinger, MD, Fox Chase Cancer Center as she presents Transitioning from Patient with Cancer to Cancer Survivor as part of the NCCN 2017 Oncology Case Manager and Medical Director Program Webinar Series.

Nearly 15.5 million cancer survivors were alive in the United States in 2016, and these numbers are predicted to reach more than 20 million by 2026 and more than 26 million by 2040. Unfortunately, many survivors experience physical, psychological, and psychosocial late and long-term effects of cancer and its treatment that can be severe, debilitating, and sometimes permanent or life-threatening.

As the numbers of cancer survivors continue to grow, educating case managers, nurses, primary care physicians, and other members of the multidisciplinary care team on the physical, psychological, and psychosocial late and long-term effects of cancer and its treatment becomes increasingly important. Knowledge of the best ways to guide patients through the critical transition from active treatment to survivorship is of particular importance to the healthcare team. If the transition is optimal, the survivor is more likely to follow surveillance, maintenance therapy, and healthy lifestyle recommendations that can improve their quality of life and decrease their chance of recurrence.

Target Audience

This program is designed to meet the educational needs of case managers, nurses in other roles (i.e., quality management and utilization review), medical directors at managed care organizations, reinsurers, TPAs, and case management and disease management companies who interact with, counsel, and refer patients with cancer to appropriate sources of care and/or make coverage decisions. Programs may also be of interest to nurses, nurse navigators/care coordinators, and physicians who work directly with patients in clinical settings as well as clinical pharmacists in managed care organizations and other settings.

Learning Objectives

Following this activity, participants should be able to:

  • Describe common challenges patients face during the transition from active cancer treatment to survivorship.
  • Explain the potential role of survivorship care plans in optimizing the transition to the survivorship phase.
  • Discuss additional ways to facilitate a smooth transition for survivors after active cancer treatment.
Additional information
Supporters: 

This activity is supported by educational grants from:

  • Astellas and Medivation, Inc., a Pfizer Company
  • AstraZeneca
  • Genentech
  • Genomic Health, Inc.
  • Olympus Corporation of the Americas
  • Taiho Oncology
  • Takeda Oncology

This activity is supported by independent educational grants from AbbVie and Boehringer Ingelheim Pharmaceuticals, Inc.

Course summary
Available credit: 
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.09 ANCC contact hours
  • 1.00 CCM clock hours
  • 1.00 Participation
Course opens: 
12/14/2017
Course expires: 
12/14/2018
Cost:
$0.00

Crystal S. Denlinger, MD
Fox Chase Cancer Center   

Disclosure of Relevant Financial Relationships
All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.

The faculty listed below discloses the following relevant financial relationships:
Crystal S. Denlinger, MD
Advaxis: Grant/Research Support
AstraZeneca Pharmaceuticals LP: Grant/Research Support
Bristol-Myers Squibb Company: Grant/Research Support
Carevive: Scientific Advisor
Eli Lilly and Company: Grant/Research Support; Scientific Advisor
EMD Serono: Scientific Advisor
Genentech, Inc.: Grant/Research Support
Incyte: Grant/Research Support
MedImmune Inc.: Grant/Research Support
Merck & Co., Inc.: Scientific Advisor
Merrimack Pharmaceuticals: Grant/Research Support
OncoMed Pharmaceuticals: Grant/Research Support

The NCCN Activity Planning staff listed below discloses no relevant financial relationships:
Kimberly Bayer; Melissa Esplen; Mark Geisler; Kristina M. Gregory, RN, MSN, OCN; Kristin Kline Hasson; Rose Joyce; Karen Kanefield; Joan S. McClure, MS; Diane McPherson; Melanie Moletzsky; Lisa Perfidio; Liz Rieder; Shannon K. Ryan; Kathy Smith; Melinda Somasekhar, PhD (until 10/30/17)

The NCCN Clinical Information staff listed below, who has reviewed content, discloses no relevant financial relationships:
Deborah Freedman-Cass, PhD

The ACCME/ANCC/ACPE defines “conflict of interest” as when an individual has an opportunity to affect CE content about products or services of a commercial interest with which he/she has a financial relationship.

ACCME, ACPE, and ANCC focuses on financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content of the CE activity. ACCME, ACPE, and ANCC have not set a minimal dollar amount for relationships to be significant. Inherent in any amount is the incentive to maintain or increase the value of the relationship. The ACCME, ACPE, and ANCC defines “relevant’ financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation to the tasks and methods of delivery.

Faculty presentations may include discussion of off-label use.  Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling.

Physicians
National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NCCN designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.0 hour of Category I credits for completing this activity.

Nurses
National Comprehensive Cancer Network (NCCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

NCCN designates this educational activity for a maximum of 1.0 contact hour.

Case Managers
This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board certified case managers. This course is approved for 1.0 CE contact hour. Activity Code: I00028899; Approval #: 170003905

Pharmacists

National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

NCCN designates this knowledge-based continuing education activity for 1.0 contact hour (0.1 CEUs) of continuing education credit. UAN: 0836-0000-17-132-H01-P

Available Credit

  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.09 ANCC contact hours
  • 1.00 CCM clock hours
  • 1.00 Participation

Accreditation Period

Course opens: 
12/14/2017
Course expires: 
12/14/2018

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
    • One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
    • Internet Explorer is no longer supported
  • Adobe Reader or other PDF reader software for certificate viewing/printing